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Protein disulﬁde isomerase (PDI) is an abundant protein primarily found in the endoplasmic reticulum
and also secreted into the blood by a variety of vascular cells. The evidence obtained here, suggests that
PDI could directly participate in the efﬂux of NO+ from red blood cells (RBC). PDI was detected both in
RBC membranes and in the cytosol. PDI was S-nitrosylated when RBCs were exposed to nitrite under
∼50% oxygen saturation but not under ∼100% oxygen saturation. Furthermore, it was observed that
hemoglobin (Hb) could promote PDI S-nitrosylation in the presence of ∼600 nM nitrite. In addition, three
lines of evidence were obtained for PDI–Hb interactions: (1) Hb co-immunoprecipitated with PDI; (2) Hb
quenched the intrinsic PDI ﬂuorescence in a saturable manner; and (3) Hb–Fe(II)–NO absorption
spectrum decreased in a [PDI]-dependent manner. Finally, PDI was detected on the surface RBC under
∼100% oxygen saturation and released as soluble under ∼50% oxygen saturation. The soluble PDI
detected under ∼50% oxygen saturation was S-nitrosylated. Based on these data it is proposed that PDI is
taken up by RBC and forms a complex with Hb. Hb–Fe(II)–NO that is formed from nitrite reduction under
∼50% O2, then transfers NO+ to either Hb–Cys β93 or directly to PDI resulting in S-nitroso-PDI which
transverses the RBC membrane and attaches to the RBC surface. When RBCs enter tissues the S-nitroso-
PDI is released from the RBC-surface into the blood where its NO+ is transferred into the endothelium
thereby inducing vasodilation, suggesting local oxygen-dependent dynamic interplays between nitrite,
NO and S-nitrosylation.
& 2013 The Authors. Published by Elsevier B.V. Open access under CC BY-NC-ND license. Introduction
When RBCs enter a hypoxic region of the vasculature they
release effector(s) that induce vasodilation thus ensuring that the
oxygen they release is effectively distributed. This phenomenon
termed hypoxic vasodilation is highly conserved and although ﬁrst
reported some 90 years ago [1–3], the sensing mechanisms as well
as the vasodilatory substances released by RBCs remain to be
clearly identiﬁed. Current research in this area supports either thatB.V.
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Open access under CC BY-NC-NDnitric oxide (NO) and related compounds (NOx) [4–6] or ATP
[7–12] as vasodilator-triggers released from RBCs.
The ﬁrst hypothesis put forward for RBC-mediated hypoxic
vasodilatation is through release of ATP upon decrease in HbO2
saturation. The ATP released diffuses to the endothelium and binds
to the purinergic receptors leading to increase NO production via
eNOS activation [7–13]. Furthermore, recent studies have shown
that deoxy-Hb interacts with nitrite and dislodges the membrane
bound glycolytic regulatory subunits enhancing intracellular ATP
that is released under hypoxic conditions [14–16]. The ATP is
released from RBC not only when RBC deoxygenates but also in
response to mechanical deformation when RBC travel through
narrow vessels [11,12]. Various factors are likely to regulate the
role of ATP in vasodilatation such as the activity of transporters
that regulate ATP release, enzymes that regulate ATP concentra-
tions and purinergic receptor expression levels [17].
The NO (or NOx) based hypotheses can be further subdivided
into those that depend on the scavenging of endothelia-generated
or more recently RBC-eNOS-generated NO [18–21] to yield
S-nitrosohemoglobin (SNO-Hb) or those that transform nitrite to
NO within the RBC by hemoglobin acting as a nitrite reductase. In
the SNO-Hb hypothesis, deoxygenated Hb in its T-state scavenges license. 
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(III)–NO. When the RBCs arrive in the lungs the Hb undergoes a
conformational change to the R-state where the O2 displaces the
heme-bound NO to Cys β93 of Hb to form SNO-Hb. When the RBC
reach the hypoxic tissues, Hb then undergoes conformational
changes to the T state which leads to the concomitant release of
O2 and transfer the SNO-bound NO bioactivity to the outside of the
RBC possibly via transnitrosation reactions to induce endothelial
vasodilatation [4,22–24].
The nitrite/nitrite reductase hypothesis involves transport of
nitrite to RBC, reaction of nitrite with deoxy-Hb, transport of NO
bioactivity from RBC and ﬁnally vasodilation [5,15,25,26]. The
plasma levels of nitrite are reportedly between ∼120 nM and
290 nM [17,27]. Recent studies suggest that plasma nitrite can
accumulate to near μM levels in RBC under hypoxia, via the
deoxyHb-mediated inhibition of the anion transporter (AE1)
which is responsible for nitrite efﬂux from the RBC [28]. Within
RBC the nitrite could be converted to NO by the previously
demonstrated nitrite reductase activities of xanthine oxidoreduc-
tase, hemoglobin [28] and eNOS [21,29–31].
The next important question concerns the mechanisms by
which intracellular NO or NO-equivalents exit the RBC which
contains ∼30 mM Hb. The amount of NO produced by the SNO-
Hb or the nitrite routes are expected to be in the submicromolar
levels. Under these conditions, any NO that is formed can react
with deoxyhemoglobin (Fe2+) and yield heme-nitrosylHb (HbNO)
which can either react with oxygen to form nitrate plus methe-
moglobin (Fe3+) or react with RBC-thiols to yield S-nitrosothiols
(SNO). The efﬂux of SNO-bound NO from RBC could be plausible
via a series of transnitrosation reactions where the SNO moiety
would be transferred/shuttled from Hb to other intracellular
proteins then to membrane spanning proteins eventually ending
up as cell surface or secreted SNO-proteins which can deliver their
NO into endothelia thus effecting vasodilation. In fact, several
studies have implicated the transmembrane anion exchanger 1
(AE1) or band 3, one of the most abundant RBC-proteins, of
accepting SNO-Hb-bound NO via transnitrosation [23,24,28,32,33].
Protein disulﬁde isomerase (PDI) is another enzyme that could
potentially play a role in the efﬂux of NO equivalents from RBCs for
the following reasons: PDI accounts for ∼1% of total cellular
proteins in mammalian cells. Although it is largely an endoplasmic
reticulum—(ER)—resident enzyme, it is secreted or leaks out of
cells where it forms weak associations with the cell surfaces of
many cell types including pancreatic cells [34,35], B cells [36,37],
hepatocytes [38], platelets [39,40], endothelial cells [41], leuko-
cytes [42,43] and platelet derived microparticles [44]. Several
studies in RBCs have identiﬁed membrane associated PDI. How-
ever, the physiological role of PDI in RBCs is unknown [40,45–47].
Previous studies have shown that in endothelial cell surface PDI
facilitates the transfer of extracellular SNO to the cytosol [48] and
that PDI catalyze the release of NO from SNO-PDI as well as other
S-nitrosothiols [49]. In this study, we report the potential involve-
ment of PDI in a nitrite-dependent and oxygen regulated process
for the efﬂux of NO (or NO-equivalents) from RBCs.Materials and methods
Materials
Buffer salts, diethylenetriaminepentaacetic acid (DTPA), ethyle-
nediaminetetraacetic acid (EDTA), penylmethylsulfenylﬂuoride (PMSF),
nonyl phenoxypolyethoxylethanol (NP-40), sodium dodecyl sulfate
(SDS), hemoglobin, sodium dithionite, biotin-maleimide and immuno-
blotting reagents were obtained from Sigma-Aldrich (St. Loius Mo).
All antibodies were purchased from AbCam (Cambridge MA). Thebicinchoninic acid assay (BCA assay), Aminolink Plus coupling resin
and spin columns were purchased from Thermo Scientiﬁc
(Rockford, Ill).
RBC preparation
RBCs were prepared for experiments under different oxygen
saturations using previously established protocols. Fresh blood
was collected from healthy human volunteers by venipunture into
BD tubes containing anticoagulant. Blood was centrifuged at
1000 g for 10 min to remove plasma and buffy coat. RBCs were
washed with buffer (pH 7.4) of following composition 6.9 g/L NaCl,
2.28 g/L NaHCO3, 0.35 g/L KCl, 0.136 g/L KH2PO4, 0.144 g/L MgSO4,
2.0 g/L D-glucose to prevent hemolysis. Experiments with differ-
ent oxygen saturations were performed in septa sealed vials.
The buffer used in the experiments was also pre-equilibrated for
30 min at respective oxygen saturations. Isolated and washed RBCs
in buffer (pH 7.4) were held under 16% O2 or hypoxia 4% O2 for
15 min [28,50]. Nitrite stock solution was prepared in phosphate
buffered saline (PBS) with DTPA (100 μM) and added to RBC
suspension to a ﬁnal concentration of 600 nM using a syringe
and further incubated for 10 min.
Immunoprecipitation
RBCs membranes were prepared using standard protocols as
described previously [17,27,51]. Brieﬂy, to the RBC pellet (1 mL) 40
volumes of ice-cold 5 mM phosphate buffer containing 0.1 mM
PMSF, 20 mM NEM and 100 μM DTPA was added. RBCs were then
incubated on ice for 20 min to induce hemolysis. After centrifuga-
tion at 12,000 g for 10 min at 4 1C, RBC membranes were washed
twice with the same buffer.
RBC membranes were dissolved as described earlier [51,52].
RBC membranes were solubilized in lysis buffer containing Hepes
(50 mM), NaCl (150 mM), EDTA (5 mM), EGTA (5 mM), sodium
pyrophosphate (20 mM), NEM (20 mM), orthovanadate (1 mM),
NaF (20 mM), K3Fe (CN)6 (10 mM), NP-40 (1%), PMSF (0.1 mM) and
protease inhibitor (1:200). The samples (100 μg) were precleared
with protein A/G (40 μL) by incubation and mixing for 1 h at 4 1C.
Samples were then incubated with anti-PDI antibody (1:50 dilu-
tion) or mouse anti AE1 antibody (1:100 dilution) or rabbit anti-
GLUT 1 antibody (1:100 dilution). After incubation for 2 h at 4 1C,
protein A/G beads (50 μL) were added to the samples and further
incubated for 3 h. The beads were washed three times with lysis
buffer. Proteins were eluted from beads using SDS-PAGE sample
buffer devoid of β-mercaptoethanol by incubating at 951 for
10 min and analyzed by immunoblotting. For experiments with
RBC homogenates, RBC samples (100 μL) were homogenized in PBS
with NEM (20 mM), K3Fe(CN)6 (10 mM), DTPA (100 μM), NP-40 (1%),
PMSF (0.1 mM) and protease inhibitor (1:200) [53] followed by
immunoprecipitation as described above.
Detection of S-nitrosylated PDI by immunoblotting
Nitrite supporting PDI-S-nitrosylation in-vitro in presence of
oxy-hemoglobin (oxyHb) was determined as follows: Hb(1 mM)
was reduced with dithionite (50 mM) under argon in septa sealed
vials and transferred to septa sealed vials containing constant PDI
(1 μM), Hb (0.6 mM) and varying amounts of nitrite (78 nM–5 μM)
in PBS. The headspace of the vial contained 20 ppm O2. After
incubation for 5 min at room temperature the samples were are
subjected to biotin switch assay as previously described [50,53,54].
The supernatant was treated with 100 μM DTPA, 20 mM NEM,
10 mM K3Fe(CN)6 and 1% SDS and incubated at 50 1C for 30 min
with frequent vortexing. Two volumes of ice-cold acetone were
added to precipitate the proteins. The precipitant was further
1 2   3
Fig. 1. Western immunoblots of: RBC membrane fraction-Lane 1; RBC homoge-
nate-Lane 2; and standard human PDI-Lane 3, all probed with anti-PDI primary
antibodies.
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100 μL of PBS followed by addition of 1 mM ascorbic acid and
1 mM biotin-maleimide and incubated in dark at room tempera-
ture for 1 h. Biotin-labeled proteins were precipitated using pre-
chilled acetone and resuspended in PBS. The concentrations of
protein in samples were determined by BCA assay. Protein
samples (8 μg/well) were resolved on non-reducing SDS-PAGE
followed by immunoblotting. The membranes were probed with
anti- Hb (1:1000), mouse anti-PDI (1:1000) and streptavidin-HRP
(1:100,000). The blots were then incubated with anti-mouse
secondary antibodies and visualized using chemiluminescence
substrate.
Preparation of Hb samples for UV spectroscopy
All reactions were carried out in PBS pH 7.4 at room tempera-
ture. Deoxy-hemoglobin was prepared as previously described
[55] Brieﬂy, hemoglobin (Hb) was dissolved in PBS pH 7.4 (8.3 mg/
ml) followed by centrifugation at 12,000 rpm for 2 min. The
supernatant was used for preparation of deoxy-Hb. Hb (1 mM)
was reduced with dithionite (0.5 mM) under argon (Ar) in septa
sealed cuvette followed by addition of sodium nitrite (50 μL of
1 mM stock, total V¼1.05 mL). The concentration of Hb(III), Hb(II)
and Hb(II)-NO were determined using the previously reported mM
extinction coefﬁcients [56,57]. Small amount of air (500 μL) was
introduced by the aid of syringe to displace the NO from the heme to
yield SNO-Hb (βCys93) [58]. The change in the [Hb(II)-NO] was
monitored at 418 nm (mM extinction coefﬁcient¼130 mM1 cm1
[55]) with an Agilent 8453 UV spectrophotometer.
NO measurements
The gas phase NO was measured using Sieverss Nitric Oxide
Analyzer (NOA 280i). In these experiments, small aliquots (10 μL)
of the immunoprecipitated PDI was injected into the NOA chamber
containing I3 dissolved in acetic acid. And compared to a NO
standard curve generated by injecting NO(aq) solutions into
the NOA.
Fluorescence measurements
Fluorescence measurements were performed on Cary Eclipse
ﬂuorescence spectrophotometer (Agilent, Canada). The excitation
wavelength was set at 280 nm to limit ﬂuorescence measurements
mainly to tryptophan. The PDI concentration used was 0.75 μM
and all measurements were performed in PBS pH 7.4. The Hb was
added from 2 mg/ml stock solution. The measured ﬂuorescence
intensity F was corrected for inner ﬁlter effects (Fcorr) using the
measured absorbance A280 at each Hb concentrations Fcorr¼
F/(110–A280) (this correction corresponds to the fraction of light
absorbed as deduced from the Beer–Lambert law).
Flow cytometry
RBC surface proteins were detected by ﬂow cytometry using
previously established protocols with some modiﬁcations [59–61].
RBCs were isolated and adjusted to ∼106 cells/ml and held at
different oxygen conditions with and without nitrite as described
above. RBC samples were immediately ﬁxed with 1% paraformal-
dehyde for 20 min, followed by washing with PBS (31 mL). RBCs
were incubated with mouse monoclonal anti-PDI antibody (1:100)
for 1 h. After washing with PBS (31 mL), RBCs were incubated
with sheep anti-mouse IgG-FITC (Stressgen Biotechnologies) for
30 min in dark. RBCs were then washed with PBS (31 mL)
and analyzed by ﬂow cytometry. RBCs labeled with only sheepanti-mouse IgG-FITC or only anti-PDI antibody were used as
controls. Data was collected for 100,000 events of RBC population.
Detection of soluble PDI
The buffer of the RBC suspension under 16% O2 and 4% O2
oxygen with and without nitrite treatment were probed for soluble
PDI. The soluble PDI was isolated as described previously [62].
The supernatant of the RBC suspension was subjected to two
centrifugation steps ﬁrst at 1000 g to remove the cells then at
13,000 g to remove cellular debris. The resulting supernatant
containing soluble proteins was used for immunoprecipitation of
PDI. The supernatant (1 mL) was precleared with protein A/G (40)
by incubation and mixing for 1 h at 4 1C. The suspension was
centrifuged at 1000 g for 1 min. 10 μg mouse anti-PDI antibodies
was immobilized on Aminolink Plus coupling resin, according to
the manufacturer′s instructions, followed by addition of 500 μL of
supernatant. After incubation for 2 h at 4 1C, the suspension was
centrifuged at 1000 g for 1 min. The beads were washed three
times with wash buffer and incubated with 100 μL of elution
buffer for 5 min. Immunoprecipitated proteins were collected by
centrifugation at 1000 g for 2 min. Protein concentrations were
determined by BCA assay. Protein samples, ∼20 μg/well, were
resolved on non-reducing SDS-PAGE gel followed by immunoblot-
ting. The membranes were then incubated with rabbit anti-PDI
antibody (1:1000) antibody for 2 h followed by HRP conjugated
anti-rabbit secondary antibodies (1:2500) for 1 h and visualized
using chemiluminescence substrate. For determining S-nitrosylation
of soluble PDI at various oxygen saturations, 10 μL of imunoprecipi-
tated protein was injected into NO analyzer. The concentration of NO
was determined from standard curve.Results and discussion
PDI is detected in RBC homogenates and membrane fractions
Recent studies indicate that PDI along with several other
chaperones are lost in erythroid progenitor cells as they mature
to become RBCs [63]. Despite this, PDI was detected on the surface
of RBCs [39,40] as well as in proteomic proﬁles of RBCs [46,47].
Here, the various components of human RBCs were probed with
the aid of anti-PDI antibodies (RL-90). Western blots indicated PDI
was present in RBC homogenates and in the plasma membrane
(Fig. 1).
RBC-PDI can be S-nitrosated in the presence of Hb plus nitrite under
oxygenated conditions
The nitrite reductase hypothesis requires a signiﬁcant portion
of the RBC Hb to be in the deoxyHb form [5,6,26]. In addition, the
intra RBC nitrite accumulation proposed by Vitturi et al. [28] also
requires large amounts of deoxyHb to inhibit Band3 thereby
blocking the efﬂux of nitrite. In current study, we explored the
ability of RBC-PDI to become S-nitrosylated upon incubation of
intact RBCs with nitrite under 4% O2 or 16% O2 saturation
SNO-PDI: streptavidin-HRP; +Hb
lane:   1 2  3 4 5    6   7 8
[NO2-] (μM) 0.078; 0.156; 0.312; 0.625;1.25; 2.50; 5.00;  5.00
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corresponds to ∼27 Torr or ∼36 μM oxygen which is the P50 for
human Hb, representing oxygenation levels in venous blood.
Therefore, at this oxygen tension, Hb is half saturated. Previous
studies [6] have demonstrated that the highest rate of nitrite
reduction takes place at the P50 of Hb which is 4% O2. The 16%
level was chosen as this represents the oxygen tension in the
arteries ∼144 μM. At this level Hb is fully saturated with oxygen.
The S-nitrosylation status of PDI was determined by the biotin
switch assay. Our data indicate that RBC-PDI is S-nitrosylated
under 16% O2 (Fig. 2, Lane 3), whereas it is not S-nitrosylated at 4%
O2 (Fig. 2, Lane 1).
The next question was to determine whether Hb was respon-
sible for nitrite-mediated PDI-S-nitrosylation under normoxia.
To do this, constant amounts of PDI (1 μM), Hb (0.6 mM-dithionite
reduced) was incubated with varying amounts of nitrite (78 nM to
5 μM) in PBS, in septa sealed vials equilibrated with 16% O2.
The PDI-S-nitrosylation was detected by the biotin switch assay
visualized with streptavidin-HRP. The results indicate that [nitrite]
as low as ∼625 nM can support PDI-S-nitrosylation (Fig. 3, Lane 4).
Furthermore, these experiments dramatically demonstrate the
requirement of Hb in the S-nitrosylation of PDI: ∼50% of PDI is
S-nitrosylated with 5 μM nitrite in the presence of Hb (Fig. 3, Lane 7).
However, there is no detectable PDI-S-nitrosylation when Hb is
excluded (Fig. 3, SNO–PDI: strepatavidin-HRP–Hb or Lane 8).PDI: anti-PDI Ab
Hb: anti-Hb Ab
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Fig. 3. Hb promotes NO2-dependent nitrosylation of PDI under normoxic condi-
tions (16%–O2): (A) These experiments were performed using constant PDI (1 μM),
Hb (0.6 mM) and varying amounts of nitrite (78 nM–5 μM) in PBS-Lanes 1–7.
The headspace of the vial contained 16% O2. The mixtures were incubated at 37 1C
for 10 min. Aliquots were then removed and added to cold acetone and prepared
for either the SNO–PDI determination by the biotin switch assay-visualized by
streptavidin-HRP or detecting HB or PDI by Western immunoblots utilizing anti-Hb
or anti-PDI, respectively as the primary antibodies. Lane 8-only contained
PDI (1 μM) plus nitrite (5 μM) and no Hb. (B) Digitized blot densities (ImageJ) of
SNO-PDI as a function of [NO2] in the presence of Hb (red circles) and absence of
Hb (black circles). Error bars represent standard deviation (n¼3).PDI co-immunoprecipitates with Hb and Hb quenches the
PDI-intrinsic ﬂuorescence
In order for Hb to be able to S-nitrosylate PDI these two
proteins must come in close contact so that the nitrosonium ion
on moiety on Cys β93-S-NO of Hb can be transferred to the free
thiols of PDI. Here we tested the potential interaction of Hb and
PDI by two different methods. First RBC homogenates were
immunoprecipitated with anti-PDI: protein A/G-sepahrose beads
and the immunoprecipitation product was immunoprobed with
either anti-PDI or anti-HB primary antibodies (Fig. 4).
As can be clearly observed (Fig. 4A and B, Lane 4) the
immunoprecipitation product contained both PDI and Hb an
indication that the two proteins interact in RBC.
The second method used for assessing PDI:Hb interactions was
to monitor the intrinsic ﬂuorescence change of PDI as a function of
Hb-dose. PDI has ﬁve tryptophan residues in its sequence and its
Trp ﬂuorescence was assumed to be similarly sensitive to the
detection of protein:protein interactions as thioredoxin [64,65].
Here, the intrinsic ﬂuorescence of PDI (0.75 μM) (λex 278 nm, λem
339 nm) decreased in a [Hb]-dependent manner (Fig. 5) with
a half-maximal decrease occurring at ∼1 μM Hb, suggesting a
dissociation constant between these two proteins of ∼1 μM or less 1  2 3
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Fig. 2. Nitrite promotes RBC-PDI S-nitrosylation under normoxia but not under hypoxia
(Lane 3) in septa sealed vials nitrite (600 nM) was introduced and incubated for 10 min.
the biotin switch assay visualized with streptavidin-HRP. The band corresponding to PDI
SDS-PAGE under identical conditions (Lane 2). (B) Digitized blot densities (ImageJ) of the
lane. Error bars represent standard deviation (n¼3).PDI can denitrosate Hb-NO
Having obtained evidence for PDI-Hb interactions the next
question was, can PDI denitrosate Hb-NO under normoxic condi-
tions? To test this Hb, under Ar, was reduced with dithionite,
exposed to nitrite. The formation of Hb-NO was identiﬁed via its
characteristic absorption spectrum with a maximum at 418 nm
(Fig. 6A).
As previously reported, the conversion Hb-NO to SNO-Hb (Cys
β93) requires the presence of oxygen [58,66]. To this end, 500 μL of
air was added to septa-sealed (Fig. 6B) samples containing Hb-NO.
The Hb-NO was stable in the presence of Ar. Upon introduction of
air, the Hb-NO peak decreased at a rate of 2.72 nM/min.
However, the rate of the decrease of the Hb-NO peak increased
∼6.5-fold to 17.7 nM/min in the presence of PDI, suggesting that
PDI can denitrosate Hb-NO. Next Hb-NO was titrated with PDI in
an attempt to determine the stoichiometry of the interaction
(Fig. 6C and D). The Hb-NO peak decreased with increasing
amounts of PDI and saturated at a ratio of 1:1 [Hb-NO] to [PDI].0
50
00
50
000
1 2 3
: (A) Freshly isolated RBCs were equilibrated with either 4% O2 (Lane 1) or 16% O2
The RBCs were lysed and the S-nitrosylation status of RBC–PDI was determined by
was identiﬁed from the electrophoretic mobility of standard human PDI subjected to
bands obtained from 3 different experiments with conditions identical to A in each
IB: anti-PDI 
1  2  3  4
IP: PDI IP: PDI 
1 2 3 4
 IB: anti- Hb
57 kD 14.7 kD
Fig. 4. Hb co-immunoprecipitates with PDI: RBC were immunoprecipitated with anti-PDI:ProteinA/G-Agarose beads and immunoprecipited proteins and various controls
were immunoblotted with either anti-PDI (A) or anti-Hb (B) primary antibodies: (A) Lane 1: PDI control; Lane 2: anti-PDI:protein A/G agarose; Lane 3: protein A/G agarose;
Lane 4: immunoprecipitation product; (B) Lane 1: Hb control; Lane 2: anti-PDI:protein A/G agarose; Lane 3: protein A/G agarose; Lane 4: immunoprecipitation product.
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Fig. 5. PDI intrinsic ﬂuorescence is quenched by Hb: The intrinsic Trp ﬂuorescence
(λex 278 nm, λem 339 nm) of PDI (0.75 μM) was monitored as a function of [Hb(III)].
The ﬂuorescence was corrected for inner-ﬁlter effects by measuring the absorbance
of the solution after each addition of Hb and using the equation. Fcorrected ¼
F=110Að280nmÞ .
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explanations for this include that the amount of O2 introduced into
the cuvette was not sufﬁcient to displace all of the Hb-NO. Another
possibility is that only some of the Hb-NO sites are accessible to
PDI at this oxygen tension.PDI associates with the RBC-surface in an O2 and nitrite-dependent
manner
As outlined in the introduction, PDI is secreted from many cells
comprising the vascular system. Fully active PDI has been detected
in the blood, in its soluble form as well as in its microparticle-
associated and cell surface-associated forms [33–42].
We wanted to determine if PDI associated with the RBC surface
and whether the surface association was dependent on O2 and
nitrite levels. To do this, RBCs were treated with and without
nitrite (50 μM) under 16% O2 and 4% O2 saturation. The PDI on the
RBC-surface was detected using ﬂow cytometer (Cytomics FC500,
Beckman Coulter, USA) using monoclonal mouse anti-PDI antibody
(primary Ab) and sheep-antimouse IgG-FITC (secondary Ab).
There was essentially no PDI detected on the surface of RBCs
under 4% O2. However, at 16% O2, in the absence of added nitrite
there was a low amount of PDI (corresponding to ∼0.65%70.2% of
total ﬂuorescence). Upon exposure to nitrite, the population
distribution increased to ∼8.6%73.8% (Fig. 7A). These results
suggest that PDI associates with the RBC surface at 16% and is
released at low (4%) O2. If this hypothesis is correct, then there
should be more soluble PDI in the suspension buffer of RBCs
exposed to 4% O2 than 16% O2. To test this, we removed the RBCs
from the buffer by gentle centrifugation and probed the RBC
suspension buffer for PDI by immunoprecipitation. Furthermore,
the immunoprecipitation products, isolated from the suspensionbuffer, were probed for the degree of S-nitrosylation by directly
injecting them into an NO-analyzer (acetic acid-iodine).
Interestingly, the amount of soluble PDI found in RBC suspen-
sions was ∼11-fold larger under 4% O2 plus nitrite in comparison to
16% O2 plus or minus nitrite, (Fig. 7B and C) the exact opposite of
the RBC surface associated PDI levels determined by ﬂow cyto-
metry (Fig. 7A). This supports our hypothesis that PDI is strongly
associated with the RBC surface under normoxia and weakly
associated under conditions of hypoxia.
Next, we determined the S-nitrosation status of soluble PDI
with the chemiluminescent NO analyzer (NOA). In these experi-
ments, immunoprecipitation product was injected into the NOA
containing iodine in acetic acid. Under these conditions protein-
SNO would be reduced to NO by I3 and detected by the NOA.
There was no detectable NO in the immunoprecipitated samples
exposed to 16% O27nitrite or those exposed to 4% O2 nitrite.
In contrast, RBC exposed to nitrite under 4% O2 yielded ∼274 pmol7
74 pmol of NO per mg protein (n¼4). This corresponds to ∼2%
SNO/mol of Hb, not surprizing in view of the lability of SNO
functionality in proteins and the ∼2 h workup required for the
isolation and analysis of the soluble PDI fraction.
We believe the data presented in this in vitro study makes a
compelling case for PDI to have a role in the efﬂux of NO
equivalents from RBCs. First, RBCs reportedly become devoid of
PDI as they mature from erythroid progenitor cells [64] yet this
protein is detected on the RBC surface [38,39] and in total cellular
proteomic proﬁles [45,46]. In addition, in the present study, we
detected PDI in membrane fractions and total cell homogenates
(Fig. 1). In addition, the fact that PDI was found to co-
immunoprecipitate with Hb (Fig. 4) indicates that PDI is also in
the cytosol of RBCs.
We can therefore speculate that RBCs pick up soluble PDI from
blood as PDI is readily secreted into the vasculature frommany cell
types [33–43]. PDI is also known to readily efﬂuxed from cells. The
current observation that it is detected intracellularly in RBC
suggests that PDI can freely cross plasma membranes in both
directions.
Our results also show that RBC-PDI is S-nitrosylated upon
exposure of RBCs to nitrite, that nitrite levels as low as 0.6 μM
could support signiﬁcant SNO–PDI formation and there was an
absolute requirement for Hb in this process (Fig. 3). In order for
PDI to get transnityrosylated from SNO-Hb (Cys β93) or directly
denitrosate Hb–Fe(II)–NO these two proteins must interact. Here,
we presented multiple lines of evidence for Hb:PDI interactions:
(1) these two proteins co-immunoprecipitate (Fig. 4); (2) the
intrinsic PDI-ﬂuorescence is perturbed in a saturable manner with
Hb (Fig. 5); and (3) we have clear UV/vis spectral evidence that PDI
can denitrosate Hb–Fe(II)–NO with a ∼1:1 stoichiometry (Fig. 6).
In order for PDI to “carry” NO-equivalents out of RBCs it must
be secreted. Here we were able to use ﬂow cytometry to show that
the PDI associates with the RBC surface in the presence of nitrite
under normoxia but not under hypoxia. And that under hypoxia
most of the PDI is secreted as soluble PDI. Furthermore, the
secreted PDI was S-Nitrosated (Fig. 7). These potentially redox
00.6
1.3
1.9
2.5
250 300 350 400 450 500 550 600
A
bs
or
ba
nc
e
Wavelength (nm)
0
8
16
24
32
0 0.25 0.50 0.75 1.00%
 D
ec
re
as
e 
at
 4
18
 n
m
 
PDI:Hb ratio 
1.1500
1.2125
1.2750
1.3375
1.4000
0 375 750 1125 1500
y = -3.825E-5x + 1.2278
y = -5.902E-6x + 1.2566
y = 9.159E-7x+ 1.3393 
A
bs
or
ba
nc
e 
(4
18
 n
m
)
Time (sec)
0.35
0.47
0.58
0.70
0.81
0.93
1.04
1.16
1.27
1.39
1.50
400 410 420 430 440
A
bs
or
ba
nc
e 
(c
or
re
ct
ed
)
Wavelength (nm)
[PDI] (μM)
0, 1.08
1.64
2.3
3.18
6.75
9.82
Fig. 6. PDI denitrosates Hb-NO: (A) Hb-(II)–NO was formed by incubating dithionite-reduced Hb(II) (10.8 μM) with nitrite resulting in the characteristic Hb-(II)–NO UV/vis
spectrum; (B) The Hb(II)–NO was monitored spectrophotometrically, with respect to time, at 418 nm under Ar (blue circles); or in the presence of air (500 μL ) (red circles);
or in the presence of PDI (3.4 μM) plus of air (500 μL) (purple circles). The Hb-NO extinction coefﬁcient used to convert ΔA(418 nm) to [Hb-NO] was 130,000 M1 cm1;
(C) Hb-(II)–NO (10.8 μM) spectrum in the presence of air (500 μL ) was recorded 10 min after incubation with and varying concentration of PDI to give Hb-NO:PDI ratio
between 0 and 10; (D) The re-plot of ΔA(418 nm) from C, corrected for the absorbance decrease by air alone, as a function of PDI:Hb-(II)-NO ratio.
Fig. 7. PDI associates with the RBC surface in an O2 and nitrite-dependent manner: (A) Representative ﬂow cytometer RBC population distributions, probed for extracellular
PDI. The RBCs (∼106 cells/mL) suspended in PBS were equilibrated in 16% O2 with either no nitrite (blue circles) or 50 μM nitrite (red circles) for 30 min then probed with
mouse monoclonal anti-PDI antibody and sheep anti-mouse IgG-FITC and analyzed by ﬂow cytometry; The results obtained for 4% O2 (not graphically displayed) were
nitrite 0.40%70.10%, +nitrite 0.35%70.12%; for 16% O2 were nitrite 0.70%70.085%, +nitrite 8.6%73.8% (S.D., n¼4); (B) Representative immunoblots of soluble PDI
detected in the RBC suspension buffer by immunoprecipitation of the RBCs exposed to either 16% or 4% O27nitrite. The immunoprecipitation product was subjected to SDS-
PAGE and immunoblotted with anti-PDI primary antibodies. (D) Digitized blot densities (ImageJ) of the immunoblots (B) error bars represent S.D. (n¼4).
V.M. Kallakunta et al. / Redox Biology 1 (2013) 373–380378regulated mechanisms for PDI–RBC surface associations are cur-
rently under investigation.
On the basis of these observations, we propose the following
mechanism for PDI mediated NO-equivalent efﬂux from RBC
(Scheme 1).Under hypoxic conditions nitrite reacts with Hb to form Fe(II)–
NO (1). PDI from the blood can equilibrate across the RBC plasma
membrane (PM) and interacts with Hb, to form a complex (2).
When the RBCs arrive at the lungs, the O2 displaces the NO from
the heme to either PDI-thiols or Hb(Cys β93) yielding SNO–PDI
Scheme 1.
V.M. Kallakunta et al. / Redox Biology 1 (2013) 373–380 379(3) or Hb-SNO. We can also speculate that under normoxia, PDI
interacts with HbSNO to yield SNO–PDI (3). Under normoxia the
SNO–PDI is attached to the RBC extracellular surface (4). Upon
entering the tissues the PDI–SNO is released from the RBC surface
(5). PDI–SNO then interacts with the endothelia releasing its NO+
or as previously demonstrated [48,49] its NO, triggering hypoxic
vasodiation (6) (Scheme 1).
In summary, the role of PDI in the export of NOx from the RBC
is supported by: (1) an oxygen-dependent mechanism of PDI
binding to the RBC membrane, PDI being bound to the membrane
in a PDI–SNO form under normoxia while being in a soluble form
readily able to cross the membrane and deliver NOx under
hypoxia; (2) this mechanism is coupled with a hypoxic nitrite
reductase activity; because we could evidence a direct interaction
between PDI and Hb, we propose an Hb-dependent redox process.
We cannot rule out the involvement of the nitrite reductase
activity of eNOS as this enzyme was reported in RBC [19,29,31].
Nitrite reduction requires nitrite inﬂux within RBC, either in the
form of HNO2 or via active transport possibly through AE-1 as
suggested [28]. This mechanism amounted in vitro 2% of SNO
efﬂux per mg Hb, a quantity that would be likely to be much
smaller in vivo, given the mM concentration of Hb in RBC.
Importantly, our work clearly suggests a dynamic equilibrium
between “reservoirs of NO” as nitrite, RSNO and NOx species,
governed by oxygen levels and mediated by PDI, leading to
multiple ways for efﬁcient hypoxic vasodilation to take place
when necessary. Given the interactions of PDI with many cell
surfaces including platelets, platelet derived-microparticles and
endothelial cells [33–43], this efﬂux mechanism may take place at
additional interfaces besides RBC/blood.Acknowledgments
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